Farmas USA

una forma de ver ZGNX

 

Acabo de leer un chart de un twittero que veía el mismo corte al alza que he puesto esta mañana, el problema es que él lo ve como el preludio de una caída mayor posterior. No sé, ya son paranoias de cada uno, yo veo que si el IBB acaba en verde hoy y mañana creo que los 260 serán coser y cantar. A partir de ahí....

ZGNX

report Q2

http://www.twst.com/update/73881-zogenix-inc-zogenix-reports-second-quarter-2014-financial-results

after con 40k acciones +5%

filing 10Q publicado hoy

http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001104659-14-057136%2Etxt&FilePath=%5C2014%5C08%5C06%5C&CoName=SYNTA+PHARMACEUTICALS+CORP&FormType=10-Q&RcvdDate=8%2F6%2F2014&pdf=

 

http://www.conferencecalltranscripts.org/summary/?id=1112122

Como puede llevar a engaño lo de "basic and diluted ..."

SNTA

SNTA

Parecen buenos datos no?

http://seekingalpha.com/pr/10685845-synta-reports-second-quarter-financial-results-and-provides-corporate-update?app=n

SNTA

Synta Pharmaceuticals beats by $0.03

announced that Anne Whitaker will join the Company as President, Chief Executive Officer and a member of the Company’s Board of Directors effective September 2, 2014. Ms. Whitaker has more than 20 years of experience in the pharmaceutical industry, principally at GlaxoSmithKline and Sanofi

Based on our current operating levels, we expect our $112.1 million in cash resources as of June 30, 2014, together with an aggregate of $12.2 million raised in net cash proceeds from additional sales of our common stock during the third quarter to-date under the at-the-market issuance sales agreements with MLV, will be sufficient to fund operations at least into the fourth quarter of 2015.

aqui el tema , digo yo, es el EPS estimado por los analistas. Y asi ha sido

SNTA

 

 

Synta Pharmaceuticals (NASDAQ:SNTA): Q2 EPS of -$0.24 beats by $0.03.

Parece que podriamos tenerla por encima de 4$ hoy mismo ...

SNTA